# Early-phase Trial to Assess the Safety and Preliminary Efficacy of BNT3214 in Adults With Advanced Solid Tumors

Source: https://onco.cc/trials/nct07455734/  
OnCo record `nct07455734` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 1/2 trial of BNT3214 in advanced solid tumours, run by BioNTech SE, now recruiting.

## Summary

Early-phase Trial to Assess the Safety and Preliminary Efficacy of BNT3214 in Adults With Advanced Solid Tumors is a phase 1/2 interventional study registered as NCT07455734 by BioNTech SE, with 533 participants planned, started 2026-03-30 and due to reach its primary completion in 2030-10. Interventions recorded: BNT3214.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-16
- Tags: pipeline; ctgov-ingest
- Registry id: NCT07455734
- Phase: 1/2
- Setting: A Phase I/IIa, First-in-human, Open-label, Multi-site, Multi-regional, Dose Escalation Trial With Expansion Cohorts to Evaluate Safety and Preliminary Efficacy of BNT3214 in Adults With Advanced Solid Tumors
- Sponsor: BioNTech SE
- Enrolled: 533

## Sources

- ClinicalTrials.gov NCT07455734: https://clinicaltrials.gov/study/NCT07455734

## Connected records

- cancers: [Metastatic cancer (cancer that has spread)](https://onco.cc/cancers/metastatic-cancer/)
- companies: [BioNTech](https://onco.cc/companies/biontech/)

---
JSON: https://onco.cc/api/v1/entities/nct07455734.json